

1 ml of solution contains: Active ingredient: Ambroxol Hydrochloride - 7.500 mg
Expectorant, mucolytic agent
Ambroxol has a secretomotor, secretolytic and expectorant effect: it stimulates the serous cells of the glands of the bronchial mucosa, increases the content of mucous secretion and the release of surfactant (aliment) in the alveoli and bronchi, normalizes the disturbed ratio of the serous and mucous components of sputum. Activating hydrolyzing enzymes
and, enhancing the release of lysosomes from Clara cells, reduces sputum viscosity. Increases the motor activity of cilia of the ciliated epithelium. Increases motor activity of ciliated epithelium, increases mucociliary transport, facilitates the excretion of sputum from the respiratory tract.
Acute and chronic diseases of the respiratory tract with the release of viscous sputum: acute and chronic bronchitis, pneumonia, chronic obstructive pulmonary disease, bronchial asthma with difficulty in sputum discharge,
bronchiectasis.
Hypersensitivity to Ambroxol or other components of the drug, pregnancy (I term),breastfeeding period.
Inside the drug is used after meals, adding to water, tea, milk or fruit juice.
Adults and children over 12 years old: the first 2-3 days, 4 ml 3 times a day (which corresponds to 90 mg of ambroxol per day), then 4 ml 2 times a day (which corresponds to 60 mg of ambroxol per day);
Children from 6 to 12 years: 2 ml 2-3 times a day (which corresponds to 30 or 45 mg of ambroxol per day);
Children from 2 to 6 years: 1 ml 3 times a day (which corresponds to 22.5 mg of ambroxol per day);
Children up to 2 years: 1 ml 2 times a day (which corresponds to 15 mg of ambroxol per day).
For children under 2 years old, the drug is prescribed only under the supervision of a physician.
The maximum daily dose for oral administration: for adults - 90 mg, for children 6-12 years old - 45 mg, for children 2-6 years old - 22.5 mg, for children up to 2 years old - 15 mg.
The drug can be used using any modern equipment for inhalation (except steam inhalers). Before inhalation, the drug is mixed with 0.9% sodium chloride solution (for optimal air moistening - in a 1: 1 ratio). Before inhalation, it is recommended to warm the inhalation solution to body temperature.